Skip to main content

Table 3 Overview of the scenario analyses results

From: Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany

Outcome

RR 25%

RR 50%

RR 62.5%

RR 75%

RR 100%

Scenarios

IC (Euro)

81,640

78,606

77,674

76,658

75,237

AVD Cost €55,000

IE (QALYs)

0.80

1.59

2.03

2.41

3.20

ICER

102,050

49,438

38,263

31,808

23,512

IC (Euro)

96,276

94,752

92,826

91,983

90,158

AVD Cost €70,000

IE (QALYs)

0.80

1.59

2.03

2.41

3.20

ICER

120,345

59,592

45,727

38,167

28,174

IC (Euro)

110,984

109,218

107,925

106,731

104,685

AVD Cost €85,000

IE (QALYs)

0.80

1.59

2.03

2.41

3.20

ICER

138,730

68,691

53,165

44,287

32,714

IC (Euro)

126,384

123,346

122,218

121,913

119,396

AVD Cost €100,000

IE (QALYs)

0.80

1.59

2.03

2.41

3.20

ICER

157,980

77,576

60,206

50,586

37,311

IC (Euro)

141,566

139,301

138,746

137,416

134,948

AVD Cost €115,000

IE (QALYs)

0.80

1.59

2.03

2.41

3.20

ICER

176,958

87,611

68,348

57,019

42,171

  1. RR Responder Rate, IC Incremental Costs in Euro, IE Incremental Effect in QALYs, ICER Incremental Cost-Effectiveness Ratio (Cost per QALY gained AVD vs BSC).